Lawrence L. Brooke -

Lawrence Brooke is the President and Owner of Patchtek Inc. and co-inventor of the Transdermal Cannabinoid Patch. He is also the president and founder of General Hydroponics, Inc.; pioneer and leader in the hydroponics market in North America and Europe with numerous dealers world-wide.

For more than 30 years, General Hydroponics has developed high quality innovative products that enable the growing of plants in challenging places like space, the Artic, deserts and hyper-dense urban environments. Among the numerous projects he supports, Lawrence provided the funding for "Natural Heroes"; a PBS documentary Series, which has won 3 Emmys since 2007 for champions of ecology.

Prior to founding General Hydroponics, Lawrence was a technical and scientific coordinator at Berkeley National Laboratory where he participated in numerous projects including magnetic fusion, super-conducting magnets and cryogenics for particle accelerators, plus solar energy and geothermal energy projects.

Dr. Cal C. Hermann -

Since 1989 Dr Herrmann has been working as Chief Scientist for General Hydroponics Inc. Previously Dr Herrmann was at the NASA - Ames Research Center, to develop water purification systems for Earth to Mars Spaceflight.

From 1977 Dr Herrmann worked at the University of California - Berkeley in the Seawater Conversion Laboratory, later transferring to the Forest Products Laboratory to work on cellulose to ethanol conversion. Dr Herrmann has also worked for West-Ward Inc., a manufacturer of generic pharmaceutical drugs as a quality control chemist, for the American Medical Association Drug Standards Laboratory and for the University of Chicago Medical Dermatology Division.

Dr Herrmann graduated from the University of Chicago with a Masters Degree in Organic Chemistry and went on to receive a Doctorate with a specialization in Electrochemistry from the University of Pierre and Marie Curie of the University of Paris.

Dr. Su II Yum -

Dr. Yum joined DURECT in 1999. Since then, he has played a huge role in the development of various parenteral and oral drug delivery systems that are based on these DURECT technologies. Prior to joining DURECT, Dr. Yum served as Senior Technical Advisor at Amira Medical in Scotts Valley, California, where he participated in the development of a pain-free blood glucose detector called AtLast¨.

Prior to joining Amira, he held a number of senior positions in project management and engineering at Alza Corporation ("Alza"). His contributions at Alza include the development of a number of Alza's enabling technologies and commercial products, most notably transdermal patch products such as, Nicoderm¨ nicotin and Duragesic¨ fentanyl systems. His fundamental insight into mass transport phenomena and product design were instrumental to his success in exploratory research, and development activities at Alza.

Dr. Yum earned his Ph.D. degree in Chemical Engineering from the University of Minnesota, and completed a Post-doctoral research in Biomedical Engineering at the University of Utah. He has more than 40 scientific publications and is the holder of more than 60 U.S. and foreign patents. Dr. Yum is a Fellow of the AAPS.